AI assistant
Sending…
XIAMEN YAN PALACE BIOENGINEERING CO., LTD. — Earnings Release 2000
Aug 31, 2000
49960_rns_2000-08-31_900749b2-62db-4f2d-9ed0-4decb14fcc61.htm
Earnings Release
Open in viewerOpens in your device viewer
Listed Company Information
![]() |
| CARRY WEALTH<0643> - Results Announcement Carry Wealth Holdings Limited announced on 31/8/2000: (stock code: 643) Year end date: 31/12/2000 Currency: HKD (Proforma) (Unaudited) (Unaudited) Last Current Corresponding Period Period from 1/1/2000 from 1/1/1999 to 30/6/2000 to 30/6/1999 ('000) ('000) Turnover : 463,338 386,564 Profit/(Loss) from Operations : 56,008 51,094 Finance cost : (8,757) (7,753) Share of Profit/(Loss) of Associates : N/A N/A Share of Profit/(Loss) of Jointly Controlled Entities : N/A N/A Profit/(Loss) after Tax & MI : 43,657 38,220 % Change over Last Period : +14.23% EPS/(LPS)-Basic : 13.46 cents 14.16 cents -Diluted : N/A N/A Extraordinary (ETD) Gain/(Loss) : N/A N/A Profit/(Loss) after ETD Items : 43,657 38,220 Interim Dividend per Share : 5.6 cents N/A (Specify if with other options) : N/A N/A B/C Dates for Interim Dividend : 25/9/2000 to 26/9/2000 bdi. Payable Date : 12/10/2000 B/C Dates for (-) General Meeting : N/A Other Distribution for Current Period : N/A B/C Dates for Other Distribution : N/A Remarks: 1. The issued shares in the Company have been listed on The Stock Exchange of Hong Kong Limited since 13th March, 2000. 2. Basis of presentation The Company was incorporated as an exempted company with limited liability in Bermuda on 18th September, 1997. The Company has not commenced any business and remained dormant since its incorporation until 26th February, 2000. On the even date, a reorganization took place in preparation for the listing of the shares of the Company on The Stock Exchange of Hong Kong Limited and the Company became the ultimate holding company of the Group. The financial information of the Group set out in the interim results announcement has been prepared as if the current group structure has been in existence throughout the two periods referred to in the announcement. 3. Turnover Turnover comprises sales at the invoiced value to customers outside the Group, after deducting sales returns and discounts, if any. 4. Basic earnings per share The calculation of basic earnings per share is based on the Group's profit attributable to shareholders of HK$43,657,000 (1999: HK$38,220,000) and the weighted average of 324,395,604 shares (1999: 270,000,000 shares) in issue during the period taking into account the 90,000,000 shares issued on the public listing. In determining the weighted average number of shares in issue, a total of 270,000,000 shares issued on incorporation of the Company and on the reorganization was deemed to have been in issue since 1st January, 1999. There is no diluted earnings per share since the Company has no dilutive potential shares. 5. In 1999, an interim dividend of HK$40,000,000 was made by a wholly-owned subsidiary to its then shareholders prior to the Group's reorganisation as mentioned in the above Note 2. |
More from XIAMEN YAN PALACE BIOENGINEERING CO., LTD.
Regulatory Filings
2026
Jun 4
Governance Information
2026
May 11
Transaction in Own Shares
2026
May 11
Notice of Dividend Amount
2026
May 11
Declaration of Voting Results & Voting Rights Announcements
2026
May 11
Regulatory Filings
2026
May 7
Notice of Dividend Amount
2026
Apr 17
Annual Report
2026
Apr 17
AGM Information
2026
Apr 17
AGM Information
2026
Apr 17
